155 related articles for article (PubMed ID: 8126059)
61. Progesterone induction of mammary carcinomas in BALB/c female mice. Correlation between progestin dependence and morphology.
Kordon EC; Molinolo AA; Pasqualini CD; Charreau EH; Pazos P; Dran G; Lanari C
Breast Cancer Res Treat; 1993 Oct; 28(1):29-39. PubMed ID: 8123867
[TBL] [Abstract][Full Text] [Related]
62. Differential effect of estrogen on the production of cyclin B1, cdc2 p34 and c-fos protein in rat uterus.
Yang LS; Marshall A; Koide SS
Endocr Res; 1994 Nov; 20(4):377-86. PubMed ID: 7882899
[TBL] [Abstract][Full Text] [Related]
63. Antitumor actions of toremifene in the 7,12-dimethylbenzanthracene (DMBA)-induced rat mammary tumor model.
Robinson SP; Mauel DA; Jordan VC
Eur J Cancer Clin Oncol; 1988 Dec; 24(12):1817-21. PubMed ID: 2975594
[TBL] [Abstract][Full Text] [Related]
64. Laboratory studies to develop general principles for the adjuvant treatment of breast cancer with antiestrogens: problems and potential for future clinical applications.
Jordan VC
Breast Cancer Res Treat; 1983; 3 Suppl():S73-86. PubMed ID: 6423014
[TBL] [Abstract][Full Text] [Related]
65. Sequential assays of hormone receptors and the Tritiated Thymidine Labeling Index in 7,12-dimethylbenz(a)anthracene-induced rat mammary cancers.
Araki K; Kimura M; Sakamoto K; Nishimura R; Yamashita J; Akagi M
Jpn J Surg; 1985 Mar; 15(2):150-9. PubMed ID: 3925207
[TBL] [Abstract][Full Text] [Related]
66. Tumor growth-stimulating and inhibiting effects of antiestrogens on the DMBA-induced mammary carcinoma of the ovariectomized, diethylstilbestrol-treated SD rat. A study on the mechanism of action of antiestrogens.
Hartmann RW
Eur J Cancer Clin Oncol; 1983 Jul; 19(7):959-64. PubMed ID: 6309529
[TBL] [Abstract][Full Text] [Related]
67. Mode of action of estra-1,3,5(10)-triene-3,17 beta-diol 3-benzoate 17-[4-(4-bis(2-chloroethyl)amino)phenyl)-1-oxobutoxy)acet ate) on human breast carcinoma xenografts in nude mice.
Kubota T; Koh J; Yamada Y; Oka S; Enomoto K; Ishibiki K; Abe O; Masui O; Asano K
Jpn J Cancer Res; 1988 Nov; 79(11):1224-9. PubMed ID: 3147278
[TBL] [Abstract][Full Text] [Related]
68. Preclinical studies with toremifene as an antitumor agent.
Robinson SP; Parker CJ; Jordan VC
Breast Cancer Res Treat; 1990 Aug; 16 Suppl():S9-17. PubMed ID: 2149286
[TBL] [Abstract][Full Text] [Related]
69. Ester derivatives of the mammary-tumor-inhibiting antiestrogen 2,3-bis(2-fluoro-4-hydroxyphenyl)-2,3-dimethylbutane.
Schwarz W; Hartmann RW; Engel J; Schneider MR; Schönenberger H
J Cancer Res Clin Oncol; 1989; 115(2):161-5. PubMed ID: 2715167
[TBL] [Abstract][Full Text] [Related]
70. Development of new drugs for endocrine tumour chemotherapy.
von Angerer E
Cancer Treat Rev; 1984 Mar; 11 Suppl A():147-53. PubMed ID: 6547370
[No Abstract] [Full Text] [Related]
71. In vitro evaluation of an estradiol-linked nitrosourea in mammary carcinomas of mouse, rat and man.
Petru E; Berger MR; Zeller WJ; Kaufmann M
Eur J Cancer Clin Oncol; 1988 Jun; 24(6):1027-32. PubMed ID: 3409940
[TBL] [Abstract][Full Text] [Related]
72. The inhibitory effect of 4-chloro-2-(2,6-dichloro-4-hydroxyphenyl)-1-ethyl-6-hydroxyindole (D 15413) on estrogen-dependent mammary tumors.
von Angerer E; Prekajac J; Schneider MR; Berger MR
J Cancer Res Clin Oncol; 1985; 110(3):216-20. PubMed ID: 4077919
[TBL] [Abstract][Full Text] [Related]
73. Effect of hematoporphyrin derivative on estrogen receptors in the dimethylbenzanthracene-mammary tumor model.
Lanzafame RJ; Rogers DW; Naim JO; Herrera HR; Hinshaw JR
Lasers Surg Med; 1987; 6(6):543-5. PubMed ID: 2952848
[No Abstract] [Full Text] [Related]
74. Enhanced and reversed growth in vitro of a pregnancy-dependent mouse mammary tumor (TPDMT-4) by a gonadotropin-releasing hormone agonist analog.
Matsuzawa A; Yamamoto T
Eur J Cancer Clin Oncol; 1982 May; 18(5):495-505. PubMed ID: 6811279
[TBL] [Abstract][Full Text] [Related]
75. 3,4-bis(3'-hydroxyphenyl)hexane--a new mammary tumor-inhibiting compound.
Kranzfelder G; Hartmann RW; von Angerer E; Schönenberger H; Bogden AE
J Cancer Res Clin Oncol; 1982; 103(2):165-80. PubMed ID: 6284766
[TBL] [Abstract][Full Text] [Related]
76. Sensitivity of the hormone dependent MXT-mouse mammary carcinoma to estradiol during tumoral growth. An autoradiographic study.
Kiss R; Paridaens R; Leclercq G; Danguy A
Eur J Cancer Clin Oncol; 1986 Jul; 22(7):849-56. PubMed ID: 3770041
[TBL] [Abstract][Full Text] [Related]
77. Chlorocarbamate-mustard-linked 1,1,2-triphenylbut-1-enes with a selective antitumor activity on mammary tumors containing estrogen receptors.
Schneider MR; Schuderer ML
J Cancer Res Clin Oncol; 1988; 114(6):583-7. PubMed ID: 3204105
[TBL] [Abstract][Full Text] [Related]
78. Anti-oestrogen action in experimental breast cancer.
Jordan VC; Naylor KE; Dix CJ; Prestwich G
Recent Results Cancer Res; 1980; 71():30-44. PubMed ID: 6768113
[No Abstract] [Full Text] [Related]
79. Evaluation of the antitumour activity of the non-steroidal antioestrogen monohydroxytamoxifen in the DMBA-induced rat mammary carcinoma model.
Jordan VC; Allen KE
Eur J Cancer (1965); 1980 Feb; 16(2):239-51. PubMed ID: 6768559
[No Abstract] [Full Text] [Related]
80. Carrier mediated action of platinum complexes on estrogen receptor positive tumors.
Knebel N; Schiller CD; Schneider MR; Schönenberger H; von Angerer E
Eur J Cancer Clin Oncol; 1989 Feb; 25(2):293-9. PubMed ID: 2702983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
